{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:26:53Z","timestamp":1794378413887,"version":"4.9.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:p>\n                    Positive surgical margin (M+), higher-grade group (GG), extraprostatic extension (EPE), seminal vesicle invasion (SV+), and tumor volume (TV) are among the factors at radical prostatectomy (RP) demonstrating strong independent correlations with subsequent biochemical recurrence (BCR). However, the prognostic significance of M+ in secondary tumors on BCR when a dominant tumor is excised with a clear margin has not been studied. A review of 1,687 RPs with multifocal prostate cancer was performed to assess GG, margin status, EPE, SV+, and TV for each individual tumor. The final analytical cohort consisted of 1,449 RPs, as patients without follow-up were excluded. The highest GG determined the dominant tumor. In tumors with equal GG, higher stage tumors were considered dominant. In tumors with equal GG and stage, a tumor with a larger TV was considered dominant. In all cases, the dominant tumor was excised with clear margins. Associations between secondary tumor margin status and BCR were evaluated using multivariable logistic regression analysis. The dominant tumors were GG1 (n=195 [13.5%]), GG2 (n=551 [38.0%]), GG3 (n=308 [21.2%]), GG4 (n=72 [5.0%]), and GG5 (n=323 [22.3%]). The median TV of the dominant tumor was 0.73\u00a0mL (range: 0.03 to 22). EPE was seen in 481 (33.2%) cases and SV+ in 77 (5.3%). In 74 (5.1%) RPs, a secondary tumor showed M+, composed of GG1 32 (43.2%), GG2 33 (44.6%), GG3 4 (5.4%), GG4 3 (4.1%), and GG5 2 (2.7%). BCR was observed in 137 (9.4%) patients, and 62 (4.3%) had persistent PSA. The median follow-up for patients with BCR was 855 days (range: 395 to 1,575) and for those without, 729 (range: 236 to 1,582),\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.045. In the Cox proportional hazards model, after adjusting for GG, TV, EPE, and SV+, M+ in secondary tumors predicted BCR (HR: 3.14;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.0002). Except for GG2 and EPE, all other RP findings correlated statistically significantly with BCR: GG3 (HR: 9.53;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.0002), GG4 (HR: 16.4;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.0001), GG5 (HR: 14.2;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.0001), TV (HR: 1.16;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.0001), and SV+ (HR: 3.03;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.0001). While published literature indicates that M+ in the dominant tumor is one of the strongest predictors of BCR, M+ in secondary tumors appears to have a lesser effect on BCR than dominant tumor characteristics.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002622","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T07:00:06Z","timestamp":1790578806000},"page":"1515-1522","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Does Positive Margin in Secondary Tumors at Radical Prostatectomy Predict Biochemical Recurrence in Multifocal Prostate Cancer?"],"prefix":"10.1097","volume":"50","author":[{"given":"Nikunj B.","family":"Shah","sequence":"first","affiliation":[{"name":"Pathology and Laboratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Menendez","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanoj","family":"Punnen","sequence":"additional","affiliation":[{"name":"Desai Sethi Urology Institute"},{"name":"Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam D.","family":"Williams","sequence":"additional","affiliation":[{"name":"Desai Sethi Urology Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radka","family":"Stoyanova","sequence":"additional","affiliation":[{"name":"Radiation Oncology"},{"name":"Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Pollack","sequence":"additional","affiliation":[{"name":"Radiation Oncology"},{"name":"Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Nahar","sequence":"additional","affiliation":[{"name":"Desai Sethi Urology Institute"},{"name":"Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipen J.","family":"Parekh","sequence":"additional","affiliation":[{"name":"Desai Sethi Urology Institute"},{"name":"Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L.","family":"Gonzalgo","sequence":"additional","affiliation":[{"name":"Desai Sethi Urology Institute"},{"name":"Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksandr N.","family":"Kryvenko","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine"},{"name":"Radiation Oncology"},{"name":"Desai Sethi Urology Institute"},{"name":"Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine"},{"name":"Department of Health Management and Policy, University of Miami Herbert Business School, Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"R1-20261111","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/ajcp\/aqae003","article-title":"Radical prostatectomy cancer grade and percentage of Gleason pattern 4 estimated by global vs individual tumor grading correlate differently with the risk of biochemical recurrence in grade group 2 and 3 cancers","volume":"162","author":"Kryvenko","year":"2024","journal-title":"Am J Clin Pathol"},{"key":"R2-20261111","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.5858\/arpa.2021-0279-OA","article-title":"Variance of tumor grade at radical prostatectomy with assessment of each tumor nodule versus global grading","volume":"146","author":"Iakymenko","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"R3-20261111","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.urolonc.2011.12.011","article-title":"Radical prostatectomy: positive surgical margins matter","volume":"31","author":"Meeks","year":"2013","journal-title":"Urol Oncol"},{"key":"R4-20261111","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.euo.2019.03.006","article-title":"Defining clinically meaningful positive surgical margins in patients undergoing radical prostatectomy for localised prostate cancer","volume":"4","author":"Martini","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"R5-20261111","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41391-023-00654-6","article-title":"Length of positive surgical margins after radical prostatectomy: does size matter?\u2014a systematic review and meta-analysis","volume":"26","author":"John","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R6-20261111","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2013.07.039","article-title":"Positive surgical margins after radical prostatectomy: a systematic review and contemporary update","volume":"65","author":"Yossepowitch","year":"2014","journal-title":"Eur Urol"},{"key":"R7-20261111","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.eururo.2015.06.046","article-title":"A contemporary prostate cancer grading system: a validated alternative to the Gleason score","volume":"69","author":"Epstein","year":"2016","journal-title":"Eur Urol"},{"key":"R8-20261111","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.5858\/arpa.2015-0487-SA","article-title":"Prostate cancer grading: a decade after the 2005 modified Gleason grading system","volume":"140","author":"Kryvenko","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"R9-20261111","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/1066896915600519","article-title":"Average weight of seminal vesicles: an adjustment factor for radical prostatectomy specimens weighed with seminal vesicles","volume":"23","author":"Tjionas","year":"2015","journal-title":"Int J Surg Pathol"},{"key":"R10-20261111","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/PAS.0b013e318162a8bf","article-title":"Positive surgical margins in areas of capsular incision in otherwise organ-confined disease at radical prostatectomy: histologic features and pitfalls","volume":"32","author":"Chuang","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R11-20261111","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/PAS.0000000000000656","article-title":"Radical prostatectomy findings in White Hispanic\/Latino men with NCCN very low-risk prostate cancer detected by template biopsy","volume":"40","author":"Kryvenko","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R12-20261111","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.urology.2013.12.054","article-title":"Biopsy criteria for determining appropriateness for active surveillance in the modern era","volume":"83","author":"Kryvenko","year":"2014","journal-title":"Urology"},{"key":"R13-20261111","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/JU.0000000000003892","article-title":"Salvage therapy for prostate cancer: AUA\/ASTRO\/SUO guideline part I: introduction and treatment decision-making at the time of suspected biochemical recurrence after radical prostatectomy","volume":"211","author":"Morgan","year":"2024","journal-title":"J Urol"},{"key":"R14-20261111","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.annonc.2024.03.010","article-title":"Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047)","volume":"35","author":"Parker","year":"2024","journal-title":"Ann Oncol"},{"key":"R15-20261111","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.5858\/arpa.2021-0048-OA","article-title":"Prostatic ductal adenocarcinoma controlled for tumor grade, stage, and margin status does not independently influence the likelihood of biochemical recurrence in localized prostate cancer after radical prostatectomy","volume":"146","author":"Kryvenko","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"R16-20261111","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.prnil.2020.12.004","article-title":"Impact of positive surgical margin on biochemical recurrence in localized prostate cancer","volume":"9","author":"Lee","year":"2021","journal-title":"Prostate Int"},{"key":"R17-20261111","doi-asserted-by":"crossref","first-page":"100147","DOI":"10.1016\/j.modpat.2023.100147","article-title":"ERG status at the margin is associated with biochemical recurrence after radical prostatectomy with positive surgical margins","volume":"36","author":"Salles","year":"2023","journal-title":"Mod Pathol"},{"key":"R18-20261111","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5534\/wjmh.2016.34.2.123","article-title":"The effect of tumor-prostate ratio on biochemical recurrence after radical prostatectomy","volume":"34","author":"Cho","year":"2016","journal-title":"World J Mens Health"},{"key":"R19-20261111","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.urolonc.2009.06.017","article-title":"Comparison of prostate cancer tumor volume and percent cancer in prediction of biochemical recurrence and cancer specific survival","volume":"29","author":"Chung","year":"2011","journal-title":"Urol Oncol"},{"key":"R20-20261111","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.juro.2008.08.037","article-title":"The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from Southwest Oncology Group 8794","volume":"180","author":"Swanson","year":"2008","journal-title":"J Urol"},{"key":"R21-20261111","doi-asserted-by":"crossref","first-page":"5823","DOI":"10.3390\/cancers14235823","article-title":"Tumor location and a tumor volume over 2.8 cc predict the prognosis for Japanese localized prostate cancer","volume":"14","author":"Baba","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R22-20261111","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/JU.0000000000004652","article-title":"Can genomic classifiers in biopsy cores with grade group 1 cancer predict higher-grade disease elsewhere in the prostate? Results from the prospective Miami active surveillance trial","volume":"214","author":"Freitas","year":"2025","journal-title":"J Urol"},{"key":"R23-20261111","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/pros.24725","article-title":"Morphologic patterns observed in prostate biopsy cases with discrepant grade group and molecular risk classification","volume":"84","author":"Greenland","year":"2024","journal-title":"Prostate"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002622","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:00:18Z","timestamp":1794376818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002622","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"2026-03-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}